$RVNC Revance Therapeutics, Inc. Insider Trading Week 37/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Revance Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Revance Therapeutics, Inc. in week 37/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Ruegg Curtis | EVP R&D and Tech Op ... | Option Exercise | M | 2.55 | 1,162 | 2,963 | 4,504 | |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Ruegg Curtis | EVP R&D and Tech Op ... | Sell | S | 20.57 | 838 | 17,239 | 13,268 | 14.1 K to 13.3 K (-5.94 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Ruegg Curtis | EVP R&D and Tech Op ... | Sell | S | 20.56 | 500 | 10,282 | 14,106 | 14.6 K to 14.1 K (-3.42 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Ruegg Curtis | EVP R&D and Tech Op ... | Sell | S | 20.51 | 500 | 10,256 | 14,606 | 15.1 K to 14.6 K (-3.31 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Ruegg Curtis | EVP R&D and Tech Op ... | Sell | S | 20.50 | 162 | 3,321 | 15,106 | 15.3 K to 15.1 K (-1.06 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Ruegg Curtis | EVP R&D and Tech Op ... | Buy | M | 2.55 | 1,162 | 2,963 | 15,268 | 14.1 K to 15.3 K (+8.24 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | BYRNES ROBERT F | Director | Option Exercise | M | 3.60 | 2,666 | 9,598 | 0 | |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | BYRNES ROBERT F | Director | Gift | G | 0.00 | 2,666 | 0 | 2,666 | 0 to 2.7 K |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | BYRNES ROBERT F | Director | Gift | G | 0.00 | 2,666 | 0 | 0 | 2.7 K to 0 (-100.00 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | BYRNES ROBERT F | Director | Buy | M | 3.60 | 2,666 | 9,598 | 2,666 | 0 to 2.7 K |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Option Exercise | M | 9.15 | 8,611 | 78,791 | 43,055 | |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Option Exercise | M | 8.70 | 48,437 | 421,402 | 106,563 | |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Option Exercise | M | 2.55 | 5,666 | 14,448 | 0 | |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Option Exercise | M | 2.55 | 5,000 | 12,750 | 0 | |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Option Exercise | M | 6.60 | 1,666 | 10,996 | 0 | |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Sell | S | 21.27 | 2,500 | 53,173 | 25,000 | 27.5 K to 25 K (-9.09 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Sell | S | 20.58 | 25,833 | 531,749 | 27,500 | 53.3 K to 27.5 K (-48.44 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Sell | S | 21.26 | 700 | 14,885 | 53,333 | 54 K to 53.3 K (-1.30 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Sell | S | 20.62 | 11,632 | 239,808 | 54,033 | 65.7 K to 54 K (-17.71 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Sell | S | 21.28 | 4,300 | 91,489 | 65,665 | 70 K to 65.7 K (-6.15 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Sell | S | 20.60 | 44,137 | 909,200 | 69,965 | 114.1 K to 70 K (-38.68 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Sell | S | 21.50 | 8,611 | 185,137 | 114,102 | 122.7 K to 114.1 K (-7.02 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Buy | M | 9.15 | 8,611 | 78,791 | 122,713 | 114.1 K to 122.7 K (+7.55 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Buy | M | 8.70 | 48,437 | 421,402 | 114,102 | 65.7 K to 114.1 K (+73.76 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Buy | M | 2.55 | 5,666 | 14,448 | 65,665 | 60 K to 65.7 K (+9.44 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Buy | M | 2.55 | 5,000 | 12,750 | 59,999 | 55 K to 60 K (+9.09 %) |
| Sep 19 2014 | RVNC | Revance Therapeuti ... | Waugh Jacob | Chief Scientific Of ... | Buy | M | 6.60 | 1,666 | 10,996 | 54,999 | 53.3 K to 55 K (+3.12 %) |